Respiratory Care

Aerogen provide high performance aerosol drug delivery systems for every stage of respiratory care.

COPD patients show improved patient response and BORG breathlessness score compared to a standard standard small volume nebulizer (SVN)¹

 

No matter what the respiratory illness, for mechanically ventilated or spontaneous breathing patients, Aerogen has the appropriate aerosol drug delivery system for the effective treatment of your patients.

COPD

Chronic Obstructive Pulmonary Disease (COPD) is one of the most serious lung diseases prevalent today affecting 65 million people worldwide.

From moderate chronic bronchitis to severe emphysema, COPD covers a range of debilitating lung conditions that limit airflow to the lungs.

The World Health Organisation (WHO) recognises that bronchodilator medications are crucial for symptomatic management of COPD and to effectively treat severe exacerbations of the disease. World Health Organisation COPD Fact Sheet

Aerogen’s ground breaking technology and high performance aerosol drug delivery systems, the Aerogen Solo & the Aerogen Ultra, have resulted in improved patient BORG breathlessness score and lung function¹.

  • 6 times more medication delivered to patients lungs²
  • Improved patient response¹
  • Potential to reduce hospital admissions from the ED compared to a small volume nebulizer3
  • Quick & easy to set-up with no added flow
  • Significantly more medication in half the time (4)
  • Improved patient response¹
  • Potential to reduce hospital admissions from the ED compared to a small volume nebulizer (3)
  • Quick & easy to set-up with no added flow

Asthma

Every day, millions of lives worldwide are affected by asthma. Difficulties in breathing mean serious health concerns and challenge the daily activities of sufferers with this respiratory condition. Healthcare experts realise that this global epidemic needs effective medical treatment:

  • According to the World Health Organisation (WHO), asthma is a chronic disease affecting 235 million people worldwide
  • World Health Organisation Asthma Fact Sheet
  • A recent study undertaken by the Global Burden of Disease (GBD) in 2014 highlights asthma needs to become a global health priority
  • The WHO believes appropriate management can control this respiratory disease and give asthmatics a better quality of life

 

Cystic Fibrosis

The Aerogen Ultra is ideal for the broad spectrum of CF medication including solutions, suspensions, proteins & peptides

Which CF medications can be delivered using Aerogen’s aerosol drug delivery technology?
Bronchodilators

Bronchodilators relax the muscle around your airways and are used to ease chest tightness. They can prepare your chest for chest physiotherapy or exercise by opening your airways.

Antibiotics

Antibiotics are used to treat, prevent and control infection. They should be taken after bronchodilators and chest physiotherapy.

Mucolytics DNase (Pulmozyme®)

DNase is used to make sputum thinner and easier to clear. It is normally prescribed once a day.

Osmotics

Hypertonic sodium chloride comes in different strengths; 3%, 6% or 7%. You may also know it as Nebusal® or Mucoclear®. It draws more water into the airways and sputum in the lung.

Corticosteroids

It is not common for people with cystic fibrosis to need aerosol delivered corticosteroids.

 

References

1. Cushen B, Alsaid A, Abdulkareem A and Costello RW. A Pilot Study To Assess Bronchodilator Response During An Acute Exacerbation Of COPD Using A Vibrating Mesh Nebuliser Versus Jet Nebuliser For Bronchodilator Delivery. ITS poster presentation. 2016. 2. Dugernier J, Hesse M, Vanbever R, Depoortere V, Roeseler J, Michotte JB, Laterre PF, Jamar F and Reychler G. SPECT-CT Comparison of Lung Deposition using a System combining a Vibrating-mesh Nebulizer with a Valved Holding Chamber and a Conventional Jet Nebulizer: a Randomized Cross-over Study. Pharmaceutical research. 2017;34:290-300. 3. Dunne R, Short SA and Dailey PA. Comparison of bronchodilator administration with vibrating mesh with adapter and jet nebulizer in the emergency department AARC Open Forum Abstract. 2016. 4. Hickin S, Mac Loughlin R, Sweeney L, Tatham A and Gidwani S. Comparison of mesh nebuliser versus jet nebuliser in simulated adults with chronic obstructive pulmonary disease. Poster at the College of Emergency Medicine Clinical Excellence Conference. 2014.